are twice as likely to be diagnosed with triple-negative breast cancer compared with white women
are more likely to be diagnosed with later-stage disease than other women
have the lowest survival rates in each stage of diagnosis.
Tripple-Negative Breast cancer is cancer that tests negative for estrogen receptors, progesterone receptors, and excess HER2 protein. This means that the growth of the cancer is not fueled by hormones or by the HER2 protein receptors, therefore treatment options are limited. Triple-negative breast cancer is more aggressive and has a poorer prognosis than other types of breast cancer.